Inhibition of TNF alpha has been shown to reduce monomeric amyloid-beta in a mouse model (Paouri et al., 2017) and as clinical improvement could be observed in AD patients it might also be a target for therapeutic interventions (Tobinick, 2009). The gene discussed is TNF; the disease is Alzheimer disease.